EUVIMEDEUVIMED entdecken
Crossref

L26/P-665 Aneuploidy persists in donor IVF cycles and exhibits distinct biological origins

D. Garro, D. Marín

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von D. Garro und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How do gamete-donor IVF cycles shape the patterns of embryonic aneuploidy, distinguishing mitotic from meiotic errors and maternal versus paternal contributions using PGT? Summary answer Gamete donor IVF cycles do not eliminate embryonic aneuploidy, and donor type differentially shapes whole chromosome and segmental aneuploidy patterns, origins, and parental contributions. What is known already Aneuploidy is a genetic leading cause of implantation failure and miscarriage in IVF and is strongly associated with maternal age. Donor gametes, particularly oocytes from young donors, are commonly used to mitigate age-related aneuploidy risk. However, limited data exist on how donor gametes influence overall embryonic aneuploidy patterns, including the distinction between mitotic and meiotic errors, and the relative contributions of maternal versus paternal meiosis. Current studies often focus on donor oocytes alone, with few analyses integrating both egg and sperm donors alongside non-donor controls. Study design, size, duration This retrospective cohort study analyzed embryo-level PGT-A results from 6,627 embryos for which parental genomic DNA was available, enabling inference of meiotic versus mitotic origin and parental contribution, processed in a single high-volume PGT laboratory over a 3.5-year period (July 2022–January 2026).The mean maternal age was 36.0 years (SD 4.2). Participants/materials, setting, methods Embryos originated from IVF cycles using donor oocytes, donor sperm, or non-donor gametes, enabling comparison across gamete sources within a single laboratory setting. High-density SNP-based PGT-A was used to detect whole-chromosome and segmental aneuploidies and to infer mitotic versus meiotic origin and maternal versus paternal contribution. Group differences were assessed using Pearson’s chi-square test and Fisher’s exact test. Main results and the role of chance Analyses were performed separately for whole-chromosome aneuploidy (WCA) and segmental aneuploidy. WCA rates were similar between autologous and sperm donor cycles (42.8% and 43.9%) but significantly lower in egg donor cycles (30.1%), consistent with a maternal age effect (χ² = 19.1; df = 2; p < 0.001). Segmental aneuploidy rates did not differ across autologous, sperm donor, and egg donor cycles (10.6%, 9.3%, and 9.1%; χ² = 1.44; df = 2; p ≈ 0.49). Meiotic errors predominated among WCA events in all groups. The proportion of meiotic WCA was comparable in autologous and sperm donor cycles (87.8% and 82.9%) but reduced in egg donor cycles (69.0%; χ² = 49.3; df = 2; p < 0.001). Within meiotic WCA, maternal and paternal contributions were similar in autologous and sperm donor cycles, while egg donor cycles showed fewer maternal meiotic events. Segmental aneuploidies showed an equal distribution between meiotic and mitotic origins across groups (χ² = 1.49; df = 2; p > 0.45). Among meiotic segmental events, parental origin differed by gamete source: paternal contributions were reduced in sperm donor cycles and maternal contributions in egg donor cycles compared with autologous controls (χ² = 19.3; df = 2; p < 0.001). Limitations, reasons for caution This retrospective, single-laboratory study may reflect laboratory-specific workflows, donor selection criteria, and clinical referral patterns. Wider implications of the findings Embryonic aneuploidy in gamete donor IVF cycles is not negligible and warrants systematic consideration, including in egg donor cycles. Segmental aneuploidies frequently arise from mitotic events, suggesting heterogeneous reproductive potential. Paternal contributions to aneuploidy, often overlooked, are evident and become particularly relevant when assessing meiotic segmental abnormalities. Trial registration number No

Zitieren

APA

Garro, D., & Marín, D. (2026). L26/P-665 Aneuploidy persists in donor IVF cycles and exhibits distinct biological origins. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.995

Vancouver

Garro D, Marín D. L26/P-665 Aneuploidy persists in donor IVF cycles and exhibits distinct biological origins. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.995

BibTeX
@article{Garro2026,
  author = {Garro, D. and Marín, D.},
  title = {L26/P-665 Aneuploidy persists in donor IVF cycles and exhibits distinct biological origins},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.995}
}
Kostenlos starten →